Advaxis (ADXS.Q), a clinical-stage biotechnology company, and Biosight, a privately held pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, announced today that the companies have entered…
Latest News
Top 5 Gainers and Losers: BB.TO, CUU.V, KC.V
Top 5 Gainers and Losers: MAX.V, RAIL.CN, FPC.V
Top 5 Gainers and Losers: RPX.V, NINE.CN, DCBO.TO
Silver bulls maintain strong uptrend!
Top 5 Gainers and Losers: WIFI.CN, RAIL.CN, BHS.V
Standard Uranium (STND.V) begins inaugural drill program at Canary Project